Sutro Biopharma Inc sell Bank of America Co.
Start price
14.03.25
/
50%
€0.85
Target price
14.03.26
€0.92
Performance (%)
-26.12%
End price
15.03.26
-
Summary
This prediction is currently being closed. The prediction for Sutro Biopharma Inc shows a convincing performance of -26.12%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sutro Biopharma Inc | - | - | - |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $1.00 price target on the stock, down previously from $11.00.
Ratings data for STRO provided by MarketBeat
In the thread Trading Sutro Biopharma Inc
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Bank_of_America_Co_ for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€0.77
19.05.25
19.05.25
€0.72
19.05.26
19.05.26
-18.92%
20.05.26
20.05.26

